Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 12;5(1):e405.
doi: 10.1097/AS9.0000000000000405. eCollection 2024 Mar.

To Dissect or Not to Dissect? The Surgeon's Perspective on the Prediction of Greater Than or Equal to 4 Axillary Lymph Node Metastasis in Early-Stage Breast Cancer: A Comparative Analysis of the Per-Protocol Population of the SINODAR-ONE Clinical Trial

Corrado Tinterri  1   2 , Giuseppe Canavese  1 , Damiano Gentile  1   2
Affiliations

To Dissect or Not to Dissect? The Surgeon's Perspective on the Prediction of Greater Than or Equal to 4 Axillary Lymph Node Metastasis in Early-Stage Breast Cancer: A Comparative Analysis of the Per-Protocol Population of the SINODAR-ONE Clinical Trial

Corrado Tinterri et al. Ann Surg Open. .
No abstract available

Keywords: axillary lymph node dissection; breast cancer; surgery.

PubMed Disclaimer

References

    1. Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast. 2012;21:678–681. - PubMed
    1. Fisher B, Jeong J-H, Anderson S, et al. . Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–575. - PubMed
    1. Bartels SAL, Donker M, Poncet C, et al. . Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial. J Clin Oncol. 2022;41:2159–2165. - PubMed
    1. Giuliano AE, Ballman KV, McCall L, et al. . Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918–926. - PMC - PubMed
    1. Tinterri C, Gentile D, Gatzemeier W, et al. ; SINODAR-ONE Collaborative Group. Preservation of axillary lymph nodes compared with complete dissection in T1–2 breast cancer patients presenting one or two metastatic sentinel lymph nodes: the SINODAR-ONE multicenter randomized clinical trial. Ann Surg Oncol. 2022;29:5732–5744. - PubMed